Načítá se...
Ribonuclease-Activated Cancer Prodrug
[Image: see text] Cancer chemotherapeutic agents often have a narrow therapeutic index that challenges the maintenance of a safe and effective dose. Consistent plasma concentrations of a drug can be obtained by using a timed-release prodrug strategy. We reasoned that a ribonucleoside 3′-phosphate co...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American
Chemical Society
2012
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3353771/ https://ncbi.nlm.nih.gov/pubmed/22611478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml2002554 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|